Cargando…
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344
Autores principales: | Zheng, Haosheng, Long, Guojie, Zheng, Yuzhen, Yang, Xingping, Cai, Weijie, He, Shiyun, Qin, Xianyu, Liao, Hongying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913489/ https://www.ncbi.nlm.nih.gov/pubmed/36765955 http://dx.doi.org/10.3390/cancers15030586 |
Ejemplares similares
-
Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Zheng, Haosheng, et al.
Publicado: (2022) -
ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine
por: Dai, Jianye, et al.
Publicado: (2013) -
MiR-199a-5p–HIF-1α-STAT3 Positive Feedback Loop Contributes to the Progression of Non-Small Cell Lung Cancer
por: Yang, Xingping, et al.
Publicado: (2021) -
Increases in Xu Zheng and Yu Zheng among Patients with Breast Cancer Receiving Different Anticancer Drug Therapies
por: Huang, Sheng-Miauh, et al.
Publicado: (2013) -
Quantitative Proteomic Analysis of Cyanide and Mercury Detoxification by Pseudomonas pseudoalcaligenes CECT 5344
por: Biełło, Karolina A., et al.
Publicado: (2023)